0.4%
Revenue Decline
Revenue decreased by 0.4% year-over-year, indicating challenges in maintaining sales levels.
Source: Source: 10-Q Income Statement, p.1
AI Takeaway
TECH's Q2 FY2026 results show a slight decline in revenue but improved operating income and net income, highlighting effective cost management despite revenue pressures.
Revenue
$295.88M
-0.39% YoY
EPS (Basic)
$0.24
++9.09% YoY
Gross Margin
64.6%
-0.63% YoY
Operating Income
$54.46M
++14.85% YoY
Filed · Analysis updated · Source: SEC EDGAR 10-Q filing
Revenue decreased by 0.4% year-over-year, indicating challenges in maintaining sales levels.
Source: Source: 10-Q Income Statement, p.1
Operating income increased by 14.9% due to reduced SG&A expenses, demonstrating effective cost control.
Source: Source: 10-Q Income Statement, p.1
Operating margin improved to 18.4%, reflecting better operational efficiency.
Source: Source: 10-Q Key Ratios, p.1
The slight decline in revenue suggests potential challenges in market demand or competitive pressures, which could impact future growth.
Source: Source: 10-Q Income Statement, p.1
Unlock 2 more detailed risk analysis
Upgrade to unlockReported EPS of $0.46 versus the $0.44 analyst consensus — a +4.0% beat for Q2 FY2026.
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $295.88M | $297.03M | -0.39% |
Cost of Revenue | $104.6M | $103.14M | +1.41% |
Gross Profit | $191.28M | $193.89M | -1.35% |
Operating Income | $54.46M | $47.42M | +14.85% |
Net Income | $38.01M | $34.89M | +8.94% |
EPS (Basic) | $0.24 | $0.22 | +9.09% |
EPS (Diluted) | $0.24 | $0.22 | +9.09% |
SG&A Expense | $113.69M | $121.45M | -6.39% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $2.52B | $2.67B | -5.53% |
Current Assets | $637.43M | $634.64M | +0.44% |
Current Liabilities | $140.43M | $161.26M | -12.92% |
Stockholders' Equity | $2.01B | $2.08B | -3.25% |
Cash & Equivalents | $172.88M | $177.55M | -2.63% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash FlowYTD | $110M | $148.24M | -25.80% |
Investing Cash FlowYTD | $-5.32M | $-26.72M | +80.10% |
Financing Cash FlowYTD | $-93.19M | $-95.41M | +2.32% |
Share BuybacksYTD | $24,000 | $75.63M | -99.97% |
D&AYTD | $49.05M | $55.22M | -11.18% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 64.6% | 65.3% | -0.63% |
Operating Margin | 18.4% | 16.0% | +2.44% |
Net Margin | 12.8% | — | — |
ROE | 1.9% | — | — |
ROA | 1.5% | — | — |
Current Ratio | $4.539 | — | — |
Other companies in Life Sciences Tools & Services
TECH's EPS increased by 9.1% to $0.24, but specific analyst estimates are not provided in the filing.
Key takeaways include a slight revenue decline of 0.4%, improved operating income by 14.9%, and a net income increase of 8.9%.
Risks include a decline in revenue, reduced operating cash flow by 25.8%, and a decrease in total assets by 5.5%.
TECH's revenue actually declined by 0.4% to $295.9M, indicating challenges in maintaining sales levels.
TECH maintains a strong current ratio of 4.54, indicating good short-term liquidity, despite a decrease in operating cash flow.